MedTrace Logo

Intervention With Lupin Protein-enriched Foods in Hypercholesterolemic Subjects

NCT01598649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2013-10-29

No results posted yet for this study

Summary

The objective of the study is to elucidate the effects of lupin protein (Lupinus angustifolius Boregine) as part of a mixed diet on cardiovascular risk factors and to clarify the role of arginine, one of the most abundant amino acids in lupin protein.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fabricated foods with lupin protein

\- Foods containing altogether 25 g lupin protein isolate (bread, roll, sausage, spread)

DIETARY_SUPPLEMENT

Mannitol

\- Placebo capsules containing mannitol (four capsules per day)

DIETARY_SUPPLEMENT

Arginine

\- Capsules containing arginine (four capsules per day with a total daily dosage of 1,6 g)

DIETARY_SUPPLEMENT

Fabricated foods with milk protein

Foods containing altogether 25 g milk protein isolate (bread, roll, sausage, spread)

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University of Jena

    lead OTHER

Principal Investigators

  • Gerhard Jahreis, Prof. Dr. · Friedrich Schiller University Jena, Institute of Nutrition, Department of Nutritional Physiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-12-31
Completion
2013-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01598649 on ClinicalTrials.gov